ARRD RESE |
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
Chart calendar ARRD RESE
db83604cdcd6ce016.8Gw51tVi87pVu2BySseh5qvkV2xDFlHKACD-8k-Vw7Y.njxcn6QFsPsx3wckBvDJieadb1QGXmGtUBCZu3_QlM-hAUqc-C3ClxPdOQ~7f92bc5b2f19916d7d72138f1aa4c4f3
Upcoming events on ARRD RESE
Past events on ARRD RESE
| Today | R&D Webinar - Pulmonary |
| 2024-06-28 13:00 | RNA Therapeutics Conference |
| 2024-06-25 14:00 | R&D Webinar |
| 2024-06-23 | American Diabetes Association Scientific Symposium |
| 2024-06-12 | Nephrology of Asian Pacific Congress |
| 2024-06-12 16:00 | Goldman Sachs Global Healthcare Conference |
| 2024-06-06 | European Association for the Study of the Liver Congress - Proteomic Analysis |
| 2024-06-06 | European Association for the Study of the Liver Congress - Intrahepatic |
| 2024-06-05 12:30 | Jefferies Global Healthcare Conference |
| 2024-06-02 01:00 | European Glaucoma Society Congress |
| 2024-06-01 15:20 | National Lipid Association Scientific Conference |
| 2024-05-31 17:30 | National Lipid Association Scientific Conference |
| 2024-05-29 05:30 | European Atherosclerosis Society Congress |
| 2024-05-28 08:49 | European Atherosclerosis Society Congress |
| 2024-05-28 06:04 | European Atherosclerosis Society Congress |
| 2024-05-23 14:00 | R&D Webinar - Part I |
| 2024-05-21 20:45 | International Conference on Antiviral Research |
| 2024-05-20 14:30 | American Thoracic Society Conference - Lung-targeted RNAi |
| 2024-05-20 14:30 | American Thoracic Society Conference - M1 mRNAs |
| 2024-05-19 14:30 | American Thoracic Society Conference - ARO-RAGE |
Annual results
| Fiscal Period | September | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 169 167 1.13% | 88,0 135 -34.65% | 138 142 -2.76% | 243 294 -17.16% | 241 264 -8.67% | 107 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | -87,2 -40,4 -115.82% | -141 -89,9 -56.6% | -168 -87,9 -91.14% | -193 -159 -21.17% | -368 |
|
EBIT Million USD | Released Forecast Spread | 61,2 67,0 -8.7% | -93,2 -59,8 -55.68% | -149 -114 -30.83% | -179 -135 -32.5% | -205 -162 -26.6% | -393 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 61,2 73,0 -16.23% | -84,6 -42,3 -99.8% | -141 -108 -29.92% | -173 -149 -16.06% | -206 -159 -29.54% | -393 |
|
Net income Million USD | Released Forecast Spread | 68,0 73,0 -6.94% | -84,6 -42,3 -99.81% | -141 -108 -29.92% | -176 -149 -18.32% | -205 -151 -36.13% | -360 |
|
EPS USD | Released Forecast Spread | 0,69 0,73 -6.03% | -0,84 -0,45 -85.64% | -1,36 -1,05 -30.06% | -1,67 -1,46 -14.41% | -1,92 -1,51 -26.73% | -3,14 |
| Announcement Date | 25/11/19 | 23/11/20 | 22/11/21 | 28/11/22 | 29/11/23 | - |
Quarterly results
| Fiscal Period | September | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 152 131 15.79% | 32,4 52,6 -38.39% | 31,6 91,2 -65.38% | 62,5 163 -61.51% | 146 45,5 221.61% | 15,8 45,4 -65.16% | 16,1 47,0 -65.73% | 3,55 29,6 -88.02% | 0,00 56,8 - | 37,1 | 38,9 | 21,7 | 22,5 | 29,2 |
|
EBITDA Million USD | Released Forecast Spread | 44,1 -20,3 317.83% | -70,3 -74,5 5.67% | -81,2 -27,2 -198.42% | -39,4 148 -126.69% | 50,8 -106 148% | -99,4 -133 25.41% | -104 -93,1 -12.21% | -132 -101 -31.23% | -86,9 | -0,80 | -28,6 | |||
|
EBIT Million USD | Released Forecast Spread | 41,6 47,4 -12.26% | -72,9 -67,6 -7.89% | -83,8 -53,8 -55.96% | -42,1 65,4 -164.46% | 48,2 -74,6 164.55% | -103 -67,5 -52.12% | -108 -67,2 -61.28% | -137 -98,0 -39.38% | -126 -42,3 -198.14% | -76,2 | -76,5 | -114 | -114 | -109 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 44,4 17,8 149.15% | -72,0 -62,7 -14.88% | -82,2 -58,3 -41% | -41,8 82,7 -150.54% | 47,7 -75,7 162.99% | -103 -63,7 -62.22% | -109 -60,4 -80.54% | -139 -101 -37.1% | -127 -38,4 -230.34% | -80,1 | -60,9 | -101 | -97,1 | -106 |
|
Net income Million USD | Released Forecast Spread | 44,4 43,9 1.1% | -72,0 -41,1 -75.24% | -85,5 -58,3 -46.76% | -41,8 72,3 -157.83% | 47,7 -65,2 173.12% | -103 -56,1 -83.67% | -110 -52,2 -110.22% | -133 -88,1 -50.76% | -125 -15,6 -705.53% | -72,0 | -48,7 | -101 | -97,1 | -106 |
|
EPS USD | Released Forecast Spread | 0,41 0,29 40.47% | -0,68 -0,47 -43.93% | -0,81 -0,52 -56.22% | -0,39 0,67 -158.51% | 0,45 -0,61 173.96% | -0,96 -0,59 -63.5% | -1,02 -0,58 -75.41% | -1,24 -0,81 -54.01% | -1,02 -0,22 -369.12% | -0,57 | -0,47 | -0,84 | -0,84 | -0,81 |
| Announcement Date | 10/05/22 | 04/08/22 | 28/11/22 | 06/02/23 | 02/05/23 | 07/08/23 | 29/11/23 | 06/02/24 | 09/05/24 | - | - | - | - | - |
More events
Past sector events for ARRD RESE
| 2024-07-11 16:00 | NURIX THERAPEUTICS, INC.: Q2 2024 Earnings Release |
| 2024-07-08 | LUMOSA THERAPEUTICS CO., LTD.: June 2024 Sales and Revenue Release |
| 2024-07-07 | TAIMED BIOLOGICS INC.: June 2024 Sales and Revenue Release |
| 2024-07-04 | PHARMAESSENTIA CORPORATION: June 2024 Sales and Revenue Release |
| 2024-06-06 | LUMOSA THERAPEUTICS CO., LTD.: May 2024 Sales and Revenue Release |
| 2024-06-06 | TAIMED BIOLOGICS INC.: May 2024 Sales and Revenue Release |
| 2024-06-05 03:51 | PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release |
| 2024-05-17 07:00 | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 2024-05-16 07:46 | BIOCON LIMITED: Q4 2024 Earnings Release |
| 2024-05-16 01:00 | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
- Stock Market
- Equities
- ARWR Stock
- Stock
- Calendar ARRD RESE
